Explore the Immuno-Oncology Abstracts Collection
Live Now - June 29, 2023
Check out the latest research in the field ahead of ASGCT's inaugural Spotlight on Immuno-Oncology! Hear more at the conference in Seattle and virtually August 1-2.
_1.png)
Read the most innovative science on novel CAR designs, cancer immunotherapy, B cell malignancies, genome and epigenome editing, and more. Then see it presented at ASGCT's first-ever immuno-oncology conference in August!
To help you navigate the collection, the Program Committee has chosen six abstracts to represent the top research in each category. See their titles below.
View the Abstracts Collection
B Cell Malignancies & Beyond
High Safety and Efficacy of CRISPR-Based Non-Viral PD-1 Locus Specific Integrated Anti-CD19 CAR-T Cells (BRL-201) in Treating Relapsed or Refractory Non-Hodgkin's Lymphoma: First-in-Human Phase I Study
Tuesday, August 1 | 11:55 AM - 12:10 PM
Novel CAR Designs and Approaches
Microbial Metabolites Guide the Engineering and Epigenetic-Metabolic Reprogramming of CAR T Cells for the Treatment of Solid Tumors
Tuesday, August 1 | 2:40 PM - 2:55 PM
TCR-Based Cancer Immunotherapy
Identification of Peptides Derived from Alternative Splicing for TCR-T Cell Therapies and Cancer Vaccines
Tuesday, August 1 | 4:45 PM - 5:00 PM
Direct In Vivo Delivery
Targeted in Vivo Generation of CAR T and NK Cells Utilizing an Engineered Lentiviral Vector Platform
Wednesday, August 2 | 9:40 AM - 9:55 AM
Genome & Epigenome Editing for Cancer Immunotherapy
CD47 Enhances CAR T Survival in NSG Recipients and Allogeneic Mice
Wednesday, August 2 | 11:45 AM - 12:00 PM
Beyond T-Cells
CD70 Knockout Provides Increased NK Cell Proliferation In Vivo
Wednesday, August 2 | 11:45 AM - 12:00 PM
Don't miss the inaugural Spotlight on Immuno-Oncology conference in Seattle, WA, or virtually, between August 1-2!
Register today to view abstract presentations and talks by field pioneers like Carl June, MD; Michel Sadelain, MD, PhD; Chiara Bonini, MD; and Paula Cannon, PhD.
Related Articles